Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Evaluation of Antimicrobial Therapy Duration for Hospital-Acquired Pneumonia Treatment

Evaluation of Antimicrobial Therapy Duration for Hospital-Acquired Pneumonia Treatment This study evaluated the duration of antimicrobial therapy for patients with hospital-acquired pneumonia. No difference in clinical outcomes was observed between patients receiving 7 or fewer days of antimicrobial therapy compared to patients who received more than 7 days of therapy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Infectious Diseases in Clinical Practice Wolters Kluwer Health

Evaluation of Antimicrobial Therapy Duration for Hospital-Acquired Pneumonia Treatment

Download PDF
4 pages

Loading next page...
1
 
/lp/wolters-kluwer-health/evaluation-of-antimicrobial-therapy-duration-for-hospital-acquired-3hoMlToZ3a

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1056-9103
eISSN
1536-9943
DOI
10.1097/IPC.0000000000000577
Publisher site
See Article on Publisher Site

Abstract

This study evaluated the duration of antimicrobial therapy for patients with hospital-acquired pneumonia. No difference in clinical outcomes was observed between patients receiving 7 or fewer days of antimicrobial therapy compared to patients who received more than 7 days of therapy.

Journal

Infectious Diseases in Clinical Practice – Wolters Kluwer Health

Published: Jan 1, 2018

References

  • Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
    Kalil, AC; Metersky, ML; Klompas, M
  • Multistate point-prevalence survey of health care-associated infections
    Magill, SS; Edwards, JR; Bamberg, W
  • Multicenter study of hospital-acquired pneumonia in non-ICU patients
    Sopena, N; Sabrià, M
  • Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
  • Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment
    Capellier, G; Mockly, H; Charpentier, C
  • Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial
    Chastre, J; Wolff, M; Fagon, JY
  • Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
    Pugh, R; Grant, C; Cooke, RP
  • Guidance for Industry. Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment
  • Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective
    Barriere, SL
  • KDIGO Clinical Practice Guideline for Acute Kidney Injury
  • Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription
    Singh, N; Rogers, P; Atwood, CW
  • Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
    Aliberti, S; Blasi, F; Zanaboni, AM
  • Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: results of a national medication utilization evaluation
    Madaras-Kelly, KJ; Burk, M; Caplinger, C